In clinical studies, thermal ablation of tumors has been shown to result in early systemic inflammation, the induction and systemic trafficking of specific anti-tumor T-cell responses involving CD4+ and CD8+ T cells [23,24] and a generalized adjuvant effect that also involved the activation of natural killer cells [25,26]. The gene discussed is CD4; the disease is neoplasm.